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1. Introduction 
Liver transplantation, is the replacement of unhealthy liver with a new liver allograft. This 
surgical procedure is now widely common all over the world in various medical centers. 
The major limiting factors of this surgery is the lack of available donors and decreased 
chance of appropriate patient selection. Anesthetic management of organ donors includes 
intensive management of heart beating and brain dead donors; however the augmentation 
of waiting list for liver and inadequate cadaveric organs resulted in elevated living donor 
transplantation rates especially for the critically ill patients who will not survive waiting 
until a brain dead donor is provided, resulting in the growing experience in anesthetic 
techniques for the management of living donors (Pickett et al, 1994; Lutz et al, 2003).  
The most common indications for orthotopic liver transplantation (OLT) in adults are 
alcoholic cirrhosis, chronic cirrhosis due to hepatitis C, primary biliary cirrhosis and 
primary sclerosing cholangitis. The most common indication for OLT in pediatric patients is 
biliary atresia, followed by metabolic disorders (alfa-1 antitrypsin deficiency, Wilson’s 
disease, tyrosinemia, Crigler-Najjar type-1 syndrome), fulminant hepatic failure, cryptogenic 
cirrhosis, neonatal hepatitis, and malignancy.  
The association of liver failure with pathologic status of all other organ systems requires a 
thorough examination of the liver host and a fastidiously scheduled anaesthesia. A detailed 
monitoring of the patient and a careful therapeutic concept is required to meet the 
extraordinary conditions during liver transplantation. This report sheds light on the 
anaesthesiological approach of the liver transplantation and summarizes suitable 
therapeutic options. 
2. Anesthetic management of the living donors 
In order to permit successful transplantation of the liver, it is necessary to provide excellent 
conditions for the donor while preserving optimal hemodynamic parameters (Pickett et al, 
1994; Lutz et al, 2003). However anesthetists may face severe hemodynamic instability, 
which is frequently seen in donors especially during the harvesting period when organs are 
removed (Pickett et al, 1994). Hemodynamic stability can be achieved by maintaining 
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sufficient organ perfusion, adequate cardiac output, avoiding excessive bleeding, keeping 
hematocrit at about 30% and preventing coagulopathies (Lutz et al, 2003). 
Invasive monitoring is obligatory to ensure sufficient organ perfusion and cardiac output, 
because of the major hemodynamic, hematologic and metabolic disturbances associated 
with hemorrhages and electrolyte imbalances that may be seen especially in right 
hepatectomy procedures (Lutz et al, 2003). During the operation, a central venous pressure 
(CVP) below 5 cm H20 is suggested in many liver transplantation protocols to decrease 
blood loss and graft edema. Chen et al. found a correlation between CVP and blood loss 
during resection of liver; however, Chhibber et al. reported no significant decrease in blood 
loss in patients with low CVP (Chen et al, 2000; Chhibber et al, 2007). Balci et al. has 
recommended an acute intraoperative normovolemic hemodilution technique and fluid 
restriction in a group of live donors (Balci et al, 2008).  
The type of the intravenous solutions are also important in liver transplantation as well as 
their amount. Although there is no definitive data about a detrimental effect, 0.9% saline is 
known to be associated with hypercloremic metabolic acidosis. The Ringer’s lactate solution 
is contraindicated because lactate metabolism will be disrupted as the liver is resected, 
furthermore serum lactate levels increase after resection. Plasmalyte may be an alternative 
being devoid of lactate, however there is no clear data that it is superior to other crystalloids. 
Despite the absence of definitive data about adverse outcome, since hydroxyethyl starch 
solutions are known to effect the coagulation system, they should be used with caution. 5% 
albumin can be used after hepatectomy, but it has also no proven benefit (Hwang and 
McCluskey, 2010). 
Preventing major life threatening bleeding during transsection of liver requires 
extraordinary attention by the surgical team. Preparation of autologous blood and 
hemodilution in operating room may prevent transfusion complications (Merritt et al, 2004).  
Anesthetic management of living donors is maintained with general anesthesia. Commonly 
used anesthetic agents such as modern inhalational anesthetics, sufentanil, fentanyl, 
remifentanil, propofol, cis-atracurium and vecuronium have no adverse effects on liver 
functions. In live donor hepatectomies, Rabie et al. investigated the effects of propofol or 
isoflurane, both of which were similar in terms of perioperative hemodynamics, blood loss, 
duration of surgery and hospital stay (Rabie et al, 2006).  
Appropriate antibiotic prophylaxis (at least 20 minutes before skin incision) including a 
third-generation cephalosporin and metronidazol covering anaerobic infections, in addition 
to venous thromboembolism prophylaxis including subcutaneous heparin or low-molecular 
weight heparin with pneumatic compression stockings should be administered. Prior to 
donor graft perfusion 1000-5000 IU intravenous heparin is administered and its reversal is 
often not needed (Hwang and McCluskey, 2010). 
Considering the rapid recovery from anesthesia and difficulties in pain control, general 
anesthesia combined with epidural anesthesia seems to be effective; a mid thoracic epidural 
application may be the best form of pain relief during early postoperative period. However, 
despite the data that epidural analgesia seems to be safe in spite of postoperative 
coagulation disorders in hepatectomy operations (Choi et al. 2007), it has been discouraged 
because of postoperative unpredictable coagulation profile and epidural hematoma risk of  
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living donors (Stamenkovic et al, 2011). On the other hand, since the kinetics of intravenous 
analgesics and opioids after liver resection have not been clarified yet, extra attention is 
required for the usage of these agents. Hwang and McCluskey reported that intravenous 
patient-controlled analgesia or intrathecal morphine may become an alternative for pain 
control in living donors. Regional techniques such as paraspinal blocks, transversus 
abdominus plane blocks, incisional field blocks are still investigated for their effect and 
safety in these patients (Hwang and McCluskey, 2010). 
3. Anesthetic management of the recipients 
Once the patient is scheduled for liver transplantation, the transplantation team has to 
consider the deterioration in the recipient functional status. All members of team, especially 
anesthesiologists should do their best to reduce the morbidity and mortality of this 
procedure in such high risk patient population. 
3.1 Preoperative evaluation and premedication 
The selection of appropriate and perfectly prepared recipient is the gold standard for the 
success of liver transplantation. Besides the complexity of the operation, most patients have 
an already disturbed physiology because of the hepatic disease, challenging the 
anesthesiologist (Table 1) (Findlay, 2002). Liver diseases strike all major organ systems 
leading to an unexpectedly chaotic scenario for the anesthesiologist, including hepatic 
failure, multiorgan dysfunction, encephalopathy, and severe metabolic disorders, and 
revealing the preoperative evaluation and premedication an essential part of the preparation 
of the patient. Besides, sepsis, metastatic malignancy, severe congestive heart failure, 
pulmonary hypertension and unresolved alcoholism are the contraindications for liver 
transplantations.  
Cardiovascular system: Since the criteria for transplantation is expanded, the age limits has 
been extended to the older ages, thus bringing ischemic heart diseases as a major problem to 
be evaluated in the preoperative period (Steadman, 2004). Although coronary angiography 
is the gold standart for this assessment, considering the usage of radiographic contrast in a 
patient group with a high-risk of renal dysfunction precludes the usage of this technique; 
leading to other screening methods such as transthoracic echocardiography in combination 
with a stress test. Exercise tests are not suitable for end-stage liver disease patients, because 
they cannot complete the test adequately. Thus, pharmacologic stress tests; stress 
echocardiography or myocardial perfusion scan have to be used instead (Niemann, 2010). 
Dobutamine stress echocardiography (DSE) is the screening method in many centers; 
including the advantage of diagnosing pulmonary hypertension and valvular heart disease 
(Niemann, 2010; Steadman, 2004). Preoperative assessment should include echocardiography 
in order to determine the baseline cardiac function and pulmonary artery pressures (Findlay, 
2002). In alcoholic liver disease, amyloidosis, hemochromatosis and Wilson’s disease 
nonischemic cardiomyopathy may be seen. However hypertrophic cardiomyopathy is rarely 
seen, it may cause dynamic left ventricule outflow tract obstruction during liver 
transplantation (Aniskevich et al, 2007). Most of the end-stage liver disease patients have a 
hyperdynamic state characterised by an increased cardiac output and arteriolar vasodilatation 
(Glauser et al, 1990). Portopulmonary hypertension may be found in these patients. Severe  
www.intechopen.com
 
Liver Transplantation – Basic Issues 
 
336 
System Patophysiologic changes related to liver failure 
Cardiovascular 
• Hyperdynamic Circulation 
 
 
 
 
 
 
 
• Portopulmonary 
Hypertension 
• High cardiac output,  
• Low resistance,  
• Increased cardiac index and left atrial 
size,  
• Mild left ventricular hypertrophy and 
ischemic heart disease; clinical 
cardiomyopathy (especially alcohol, 
amyloid, Wilson’s hemochromatosis);  
• Autonomic neuropathy (mild in 
cirrhosis, moderate in amyloid) 
Respiratory 
• Hypoxia • Restrictive pattern (ascites),  
• Pleural effusion;  
• Flow-related or anatomical 
intrapulmonary shunting 
(hepatopulmonary syndrome);  
• Non-cardiogenic pulmonary edema 
(fulminant hepatic failure);  
• Obstructive airways disease 
(especially cystic fibrosis, alpha-1 anti-
trypsin deficiency);  
• Interstitial lung disease (primary 
biliary cirrhosis) 
Hematologic 
• Coagulopathy 
 
 
 
 
 
• Anemia 
• Decreased and defective synthesis of 
Vit K dependent clotting factors,  
• Trombocytopenia (hypersplenism or 
marrow depression),  
• Platelet dysfunction;  
• Low grade DIC and/or 
hyperfibrinolysis 
Central Nervous 
System 
• Hepatic encephalopathy 
• Cerebral edema (fulminant 
failure) 
 
Renal System, 
Electrolyte and 
Metabolic disorders
 
• Hepatorenal Syndrome 
(prerenal failure from 
splanchnic ‘steal’);  
• Acute tubular necrosis from 
sepsis;  
• Tacrolimus/cyclosporin-
related renal impairment; 
renal tubular acidosis 
• Hyponatremia 
• Hypomagnesemia,  
• Hyperkalemia,  
• Hypokalemia, and/or 
metabolic acidosis and 
hypoglycemia 
 
Table 1. Patophysiologic changes related to liver failure (Findlay, 2002; Ozier & Klinck, 2008) 
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portopulmonary hypertension is associated with increased perioperative mortality and right 
heart failure (Krowka et al, 2000; Ramsay et al, 2000). For detecting preoperative 
portopulmonary hypertension, transthoracic echocardiography may be reliable enough in 
experienced hands, but echocardiography should be reperformed.  
Respiratory system: Respiratory complications seen in liver disease include restrictive lung 
disease, intrapulmonary shunts, pulmonary hypertension and ventilation-perfusion 
abnormalities. Hypoxemia is often related to the restrictive lung disease caused by ascites 
and/or pleural effusions, frequently responding to fluid removal. However, hypoxia may 
occur in the absence of ascites or intrinsic pulmonary disease, then this is called 
hepatopulmonary syndrome; contributing to shunting, ventilation-perfusion mismatch 
and/or diffusion defects. The presence of pulmonary hypertension responding to 
vasodilators is not a contraindication for transplantation. Pulmonary hypertension may 
improve, persist or develop following transplantation (Steadman, 2004). 
Hematological system: In addition to the routine blood tests; coagulation tests and arterial 
blood gases should also be obtained (Findlay, 2002). In the normal hemostasis, liver is 
important for the production of prothrombin, fibrinogen, factors V, VII, IX and X (except 
von Williebrand factor-synthesized in endothelial cells), sythesis of antithrombotic 
modulating factors (protein S, protein C and antithrombin III) and components of 
fibrinolytic system (plaminogen and α2-antiplasmin); also the clearance of activated 
coagulation factors. As the liver function is impaired, this natural balance between 
coagulation and its inhibition is impaired, whereas the balance between the fibrin 
polymerization and fibrinolysis is also disturbed; which occurs due to the decreased 
production of antiplasmin and inadequate clearance of tissue plasminogen activators, 
(Hannaman&Hevesi, 2011). All the coagulation factors are decreased, except fibrinogen 
and factor VIII. Besides, Fitzgerald factor, alpha-1 antitrypsin, alpha-2 macroglobulin, 
antithrombin-III and plasminogen levels are all decreased. Fibrin degradation products are 
positive in one third of the patients. Thrombocytopenia occurs in 70% of the patients, often 
complicated with the functional derangement of the platelets. For the best approach to treat 
coagulopathic disorders, defects must be identified in laboratory screening tests to predict 
bleeding risk in recipients, but the liver diseases have complicated effects on the balance 
between prohemostatic and antihemostatic mechanisms. Prothrombin time (PT), the 
activated partial thromboplastin time (APTT) and platelet count shows the defect in 
procoagulant functions. Unfortunately, defects in inhibitory pathways are less clear. The 
net effect of instability of these systems is unpredictable and administration of fresh frozen 
plasma (FFP), platelets and other blood products before the surgery should be 
reconsidered. There is a correlation between the severity of preoperative coagulopathy and 
intraoperative requirement for blood and blood products; as the severity increases, 
requirements are increased. Chronic disease anemia, malnutrition and bleeding is also 
common in recipients. In patients with the coagulation disorders intramuscular injections 
should be avoided. 
Central nervous system: In advanced liver diseases, hepatic encephalopathy within a range 
of mild stupor, deep coma and unresponsiveness, is often seen. Diuretic therapy, 
gastrointestinal bleeding, infections and advancement in liver disease worsen encephalopathy. 
In order to exclude a preexisting organic disease mimicing hepatic encephalopathy, EEG, 
stimulated potential tests and computed tomography are recommended to be performed. 
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Any organic disease, that contributes to the changes in cerebral functions, is a 
contraindication for liver transplantation. Cerebral edema occurs in 50% of the patients with 
acute fulminant hepatitis. Cortical atrophy and non-specific changes are also seen at variable 
degrees in patients with chronic liver disease. Chronic liver disease is rarely associated with 
cerebral edema, but hepatic clearance failure leads to accumulation of toxins and alterations 
in endogenous transmitters, messengers such as γ-amino butyric acid (GABA), glutamate 
and nitric oxide. In preencephalopathic patients benzodiazepines should be avoided. In 
fulminant liver failure with Grade III-IV encephalopathy intracranial pressure monitoring 
may be required in order to maintain cerebral perfusion pressure >60 mmHg (Ozier&Klink, 
2008). A severe coagulopathy may result in intracranial hemorrhage. 
Renal system: The most common cause of renal failure associated with hepatic failure is 
hepatorenal syndrome, which is characterized by the absence of primary renal disease, 
proteinuria, hypovolemia and hemodynamic cases of renal hypoperfusion. Treatment with 
vasoconstrictors improving splanchnic vasodilation, decreasing endogenous vasoconstrictors 
leading to an improvement in renal blood flow is often successful (Duvoux, 2002; Gines, 
2004; Wong, 2004). Contrast for diagnostic procedures and nephrotoxic agents should be 
avoided in these patients. Even a less advanced renal disease deserves management because 
it may also worsen the posttransplant period (Davis, 2002).  
Gastrointestinal system: Esophageal varices, portal hypertension, ascites are frequently 
seen in patients with end-stage liver-disease. This complex state also includes delayed 
gastric emptying which contributes to a major problem especially during the induction of 
the anesthesia, thus premedications should include "aspiration" prophylaxis with ranitidine, 
metoclopramide, and particulate-free antacid. 
Endocrine system: In liver diseases it is widely known that the carbonhydrate and protein 
metabolism is impaired, and glucose intolarence and insulin resistance occur. Serum insulin 
level is increased both because of the hypersecretion and decreased clearance. In addition to 
this, in acute fulminant hepatitis, depletion of glycogen stores, decreased gluconeogenesis 
and other humoral changes may result in a severe hypoglycemia. In advanced liver diseases, 
severe reductions in albumin levels may also be seen (<2gr).  
Drug metabolism: All the plasma proteins, especially albumin which mainly provides 
plasma oncotic pressure, are produced in liver, except gama-globulin. The decrease in 
albumin levels (<2gr) results in intra- and extravascular volume changes, leading to an 
increase in distribution volume of drugs (e.g. neuromuscular blocking agents). Also, the 
duration of action of some anesthetic agents (such as opioids) are prolonged because of the 
increased volume of distribution and decreased metabolism. End-stage liver disease patients 
may be resistant to some drugs due to increased binding to globulin. Thus, initial dosages of 
the drugs are increased; on the other hand, because of the decreased levels of albumin, the 
unbound fraction of the drugs is increased; which leads to increased effectivity and duration 
of action of these drugs. 
Premedication is usually administered unless the patient has an advanced hepatic 
encephalopathy. Oral diazepam 5-10 mg, lorazepam 2-3 mg can be used for adult patients, 
whereas 0.1-0.2 mg/kg of diazepam can be used orally for pediatric group of patients. 
Intramuscular injections should be avoided in patients with coagulopathy. Low dose 
midazolam (1-2 mg/kg) has become a routine before induction in the anesthetic practice. 
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All patients should be considered to have full stomach; H2 receptor blockers and 
particulate-free antacids can be used preoperatively. 
3.2 Monitoring 
Routine monitoring consisting of electrocardiography, pulse oximetry, capnograph and 
temperature monitor should be in place (Findlay, 2002). Full invasive monitoring including 
direct arterial blood pressure (close monitoring of the systemic pressures, also facilitating 
frequent blood sampling) (Peterfreund and Allain, 2003), central venous, and pulmonary 
artery pressure measurements are obligatory for the management of severe coagulopathy, 
metabolic disorders, massive blood loss, temperature alterations, hemodynamic instability, 
and other organ dysfunctions (Table 2).  
Monitoring 
• ECG 
• Pulse Oximetry 
• Capnography 
• Temperature 
• Arterial Catheter 
• Central Venous Catheter 
• Pulmonary Artery Catheter 
• Transesophageal Echocardiography 
Table 2. Monitoring during liver transplantation (Findlay, 2002; Peterfreund and Allain, 2003) 
ECG: ECG monitoring is a cornerstone showing clinical outcome of electrolyte changes. Due 
to the rapid and profound changes in electrolyte levels during the various phases of liver 
tranplantation, ECG may reflect the cardiac disturbances; which require prompt treatment. 
Fatal ventricular fibrillation due to the hyperkalemia during reperfusion period has also 
been reported (Ozier & Klink, 2008). 
Arterial blood pressure: Invasive arterial blood pressure monitoring is essential for 
providing continuous monitoring to see frequent hemodynamic changes usually secondary 
to surgical manipulations such as caval clamping, sudden blood loss, hepatic reperfusion 
during liver transplantation and also providing access for blood sampling for coagulation 
tests. Radial artery pressure monitoring may underestimate aortic pressure in hypotensive 
scenarios and femoral arterial systolic pressure is higher than radial, and the use of 
vasoconstrictors increases these variances (Arnal et al, 2005). 
Central venous cannulation and pulmonary artery catheterization: Pulmonary artery 
catheterization (PAC) and CVP monitoring are standards in many centers. Liver transplant 
recipients are hyperdynamic, characterized by increased cardiac output (CO) and decreased 
peripheral vascular resistance (SVR) and arterial pressure (Liu et al, 2006; Moller & 
Henriksen, 2008). The patients with cirrhosis have a reduced total blood volume index 
(Henriksen et al, 1989), because of this relative hypovolemia, adequate volume management 
during liver transplantation is a gold standard for improvement of tissue perfusion 
(Nasraway et al, 1995). The various phases of liver transplantation may limit the accuracy of 
CVP measurements, however considering the low CVP approach to reduce blood loss and 
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liver congestion, central venous cannulation is necessary (Niemann, 2010). Central venous 
cannulation can be applied before or after anesthetic induction and endotracheal intubation. 
However, the patients with encephalopathy, tense ascites, respiratory compromise caused 
by atelectasis or pleural effusions, may not tolerate the Trandelenburg position and draping 
of the face that are required for the central cannulation; thus it may be more suitable 
performing these procedures after the induction of anesthesia (Peterfreund and Allain, 
2003). Although less invasive monitoring gets more popular nowadays, because of severe 
PAC-induced ventricular arrhythmias (Gwak et al, 2007); PAC may still be particularly 
useful in renal insufficiency, respiratory compromise or unstable hemodynamics that exist 
prior to surgery (Peterfreund and Allain, 2003). 
Transesophageal echocardiography: Transoesophageal echocardiography (TEE) is 
increasingly used for cardiac monitoring. It is relatively noninvasive and provides visual 
information on valvular and ventricular function and gives a chance of diagnosis of 
embolization, but unfortunately it is not available in many centers (Burtenshaw et al, 2006). 
In a report of multi transplant centers the rate of PAC and TEE used was respectively 30% 
and 11.3% (Schumann et al, 2003). During the last decade, transpulmonary thermodilution 
has been becoming popular to measure circulating blood volumes (Shippy et al, 1984). In 
recent years, noninvasive techniques such as lithium thermodilution is compared with PAC 
(Costa et al, 2008). Vigileo monitor is a good choice at low and normal CO, but is not 
appropriate for the hyperdynamic cirrhotic patients (Della et al, 2008; Biancofiore et al, 2009; 
Biais et al, 2008) (see also Future Directions for Circulatory Monitoring). 
Temperature: Large insicions and prolonged duration of the procedure result in a high risk 
of hypothermia; to prevent the heat loss warming devices, heated humidifier, warming 
blanket, and a forced-air warming device should be present (Findlay, 2002).  
Venous access: Sufficient large-bore venous access should be in place in case of a sudden, 
massive hemorrhage. Since the procedure involves inferior vena cava (IVC) obstruction; the 
cannulas should be in the upper part of the body. This venous access is also needed for the 
return of blood if veno-venous bypass (VVB) is used. Peripheral or central often two 8F or 
larger cannulas are preferred. A rapid infusion pump should be ready to infuse blood or 
fluids warmed to 37 C at a rate of 1.5L/min (Findlay, 2002).  
Other monitors: All patients have nasogastric tubes and bladder catheters (Peterfreund and 
Allain, 2003). Nasogastric tubes should be used with caution because of the possible 
esophageal varices and coagulopathies that may cause bleeding (Topal & Celik, 2009). 
Future directions for circulatory monitoring: A perfect monitoring device for circulation 
has not been clearly defined yet. There are ongoing investigations for continuous 
hemodynamic monitoring such as the FloTrac/Vigileo (Edwards Lifesciences, Irvine, CA, 
USA), which is a self-calibrating arterial pulse contour cardiac output monitoring system; 
and LİDCO (LiDCO Cardiac Sensor System, London, UK) which is a pulse contour waveform 
analysis system. However, because of the various changes in hemodynamics during phases 
of liver transplantation, these monitors lose their accuracy. Similarly, thermodilution 
technique may also become inaccurate because of the rapid changes in temperature, rapid 
infusion of fluids and changes due to reperfusion of the graft. It is difficult to recommend 
one monitor as a superior to the other, so while planning monitoring, one of the devices 
including PAC, CVP and TEE is going to be chosen in addition to arterial line or lines 
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(sometimes two arterial lines are preferred) (Liu et al, 2011). As the correlation between the 
pathophysiology of hepatic microcirculation and ischemia/reperfusion injury has been 
demonstrated, intraoperative analysis if ischemia/reperfusion-induced impairment of 
hepatic microcirculation has gained interest. Orthogonal polarization spectral imaging has 
been used accurately for this purpose; quantifying the sinusoidal perfusion rate, vessel 
diameter and venular RBC velocity (Puhl et al, 2005). 
3.3 Anesthetic induction and maintenance 
Drug metabolism and clearance depend on the state of liver blood flow and P450 
cytochrome system in hepatocytes. Due to the various disease states with different patterns 
of liver dysfunction, there is not a standard protocol for any drug. Drug biotransformation is 
related to the anesthetic practice in two ways. One of them is the sensitivity to the 
microsomal enzyme induction accelarate the biotransformation; the inhalational anesthetic 
agents and barbiturates cause microsomal enzyme induction. The second one is the 
impairment of hepatic blood flow in hepatic diseases leading to an increase in half-lives of 
drugs, because of the decrease in their biotransformation rates. In advanced liver diseases, 
the half-lives of meperidine, lidocaine and diazepam have been shown to be increased, 
similar to the duration of action of thiopenthal. In healthy patients thiopenthal binds to 
protein at a rate of 75%, while 50% in liver diseases. Thus, considering the decrease in 
metabolism and protein binding of the drugs in these patients, it should be kept in mind 
that intermittent dosing and usage of different drugs as combinations may result in 
accumulation of these drugs, which is very important in anesthetic practice. 
Careful monitoring of drug effects with titrating the drug, considering the coagulation 
profile, volume status, and general hemodynamic state of patients, is important for 
clinicians to be current in their understanding of how transplant patients should be 
managed.  
After preoxygenation, the induction of anesthesia may be performed by using either one of 
the hypnotic agents, thiopental or ketamine using invasive monitoring, and also midazolam 
can be used for its amnestic properties and minimal effects on hemodynamics. A routine 
rapid sequence induction with cricoid pressure should be performed because of the risk of 
aspiration. A semi-upright position can be applied until the abdomen is open; in order to 
prevent rapid oxygen saturation and to facillitate ventilation. Liver failure associated with 
renal dysfunction with increased potassium levels may prevent the usage of succinylcholine 
(Peterfreund and Allain, 2003). The pharmacokinetic changes, increase in extracellular 
volume, decrease in serum albumin and glycoprotein levels and elevated bilirubin and other 
metabolites in liver disease; result in an increase in the requirement of first dose of non-
depolarizing muscle relaxants and prolong the duration of their action. Because of the 
organ-independent elimination and diminished histamin release cis-atracurium and 
atracurium are preferred; however, the others can also be used safely (Topal&Celik, 2009); 
vecuronium bromide and rocuronium as neuromuscular blocking agents provide optimal 
conditions. The new liver graft may be evaluated by vecuronium since the time for the 
return of a train-of-four (TOF) with a nerve stimulator correlates with the function of the 
new liver (Lukin et al, 1995). Similarly, the duration of action of rocuronium is also used for 
the assessment of allograft function; >150 minutes refers to allograft dysfunction (Marcel et 
al, 1997). 
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In the intraoperative period; using lower tidal volumes (6-8 ml/kg) and avoiding positive 
end-expiratory pressure may lower the preload and decrease the risk of bleeding 
(Hannaman&Hevesi, 2011). Different variations have been used for anesthesia maintenance 
and all have been informed to have less side effects on liver functions (Adachi et al, 2003). 
Maintenance of anesthesia can be provided by using isoflurane, desflurane or sevoflurane 
(Lukanovic et al, 2008) in an air-oxygen mixture with their minimal metabolism in the liver, 
supplemented with sufentanil or remifentanil infusions. Isoflurane has been the volatile 
agent to be preferred because of its vasodilation effect on hepatic circulation, which is 
advantageous for the reperfused graft, preserving splanchnic blood flow better than the 
others; especially when it is compared to the vasoconstrictor effects of halothane. 
Investigations addressing the effects of desflurane has conflicting results. In an animal study 
it has been shown to decrease hepatic blood flow in a dose dependent manner at 
concentrations up to 1 MAC; however in a human study although excluding patients with 
hepatic diseases and the results were not significant, it has been shown to provide better 
hepatic blood flow compared to that of isoflurane. In another study comparing the effects of 
desflurane and sevoflurane in terms of hepatic blood flow and hepatocellular integrity; both 
agents well preserved the hepatic functions, but decreased the splanchnic perfusion and 
oxygen delivery to the liver disturbing the hepatocellular integrity and gastric tonometry. 
The increased metabolism of sevoflurane which is a hundred times that of desflurane is not 
known to cause a detrimental effect on the liver (Steadman, 2004). In one of our study, we 
investigated the effects of sevoflurane in terms of metabolism and renal functions in liver 
transplantation, and sevoflurane seemed to have minimal effects on the kidney during liver 
transplantation (Kanbak et al, 2007). Erdem et al. reported a case of liver transplantation for 
the effects of sevoflurane in terms of extrahepatic metabolism and possible nephrotoxicity in 
liver disease; revealing a correlation between the levels of N-acetyl glucoseaminidase 
excretion and urine fluoride levels and no impairment in serum BUN and creatinin levels 
(Erdem, 2006). In fulminant hepatic failure, due to the elevated intracranial pressure, volatile 
anesthetic agents should be avoided or used with caution at lower dosages combined with 
ICP monitoring (Steadman, 2004). As an intravenous anesthetic agent propofol is another 
good alternative. Takizawa et al. found that during the anhepatic phase, compared with the 
dissection phase, the clearance of propofol was decreased and afterwards liver allografts 
immediately metabolized propofol (Takizawa et al, 2005). Morphine and propofol which 
rely on conjugation pathway may be more tolerated (Brown et al, 1993). 
Rossaint et al. combined early postoperative extubation and restrictive intraoperative fluid 
management techniques in liver transplant recipients (Rossaint et al, 1990). This approach 
resulted in rapid recovery of new liver functions and favoured early extubation. Early 
extubation is a goal for the operating team, because early liver graft recovery is associated 
with early patient recovery. Postoperative mechanical ventilation following liver 
transplantation is not required nowadays in the majority of patients, since immediate 
postoperative extubation is usually safe and well tolerated. In poor clinical condition with 
severe preservation injury, special attention is required in extubation. These patients may 
not be appropriate for fast tracking protocols and may be at elevated risk of prolonged 
postoperative ventilation. 
Although the progress in liver transplantation owing to improved techniques in medicine is 
excellent, maintaining the stability of the patient who has marginal liver functions is 
critically complicated. 
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3.4 Hemodynamic and haematological management: The three phases of liver 
transplantation 
3.4.1 The preanhepatic phase 
The preanhepatic phase involves dissection and mobilization of the liver. Hemodynamic 
instability may be seen as a result of drainage of liters of ascitic fluid, transection of large 
varices and surgical manipulation of the liver, temporarily obstructing venous return. 
However, in this period of liver transplantation, the primary issue is surgical bleeding. 
Several approaches have been applied to reduce bleeding: preoperative autologous blood 
donation, erythropoietin administration, intraoperative isovolemic hemodilution, blood 
salvage, maintenance of low intraoperative central venous pressure (CVP), and 
normothermia to prevent hypothermia-induced coagulation abnormalities (Chibber et al, 
2007). The low CVP approach maintaining the pressure at or below 5 cm H2O has been 
shown to provide an 80% reduction in blood loss, although the usage of this strategy still 
remains controversial (Liu & Niemann 2011). Fluid resuscitation results in a decrease in 
coagulation factors and platelet count (Murray et al, 1995). Packed red cells and fresh frozen 
plasma should be prepared at this time. During this time period for the evaluation of the 
coagulation, thromboelastograph and standard laboratory tests (prothrombin time, 
fibrinogen and platelet count) can be used. Monitoring coagulation parameters differs, but 
the prothrombin time, INR, partial thromboplastin time, fibrinogen and platelet counts are 
monitored in most of the transplantation centers. While thromboelastography is used in 
approximately 33% of centers, the activated clotting time is used in approximately 18% of 
centers (Schumann et al, 2003). Excessive treatment of coagulopathy is not usually 
recommended at this phase unless bleeding is extreme. As a result of improved 
intraoperative techniques, some centers reported average RBC transfusion rates as low as 2 
U (De Boer et al, 2005). The requirements for the blood products has been reduced for over 
the last decade, that several reports revealed the number of liver transplants without any 
administration of blood products has been increased. Because, blood tranfusion may have 
its own adverse events such as; subacute transfusion complications including fluid overload, 
hypothermia, hypocalcemia, hyperkalemia, acid-base disturbances; and more seriously, 
acute hemolytic transfusion reactions, infusion of a bacterially contaminated unit, tranfusion 
associated lung injury, severe allergic reactions and anaphylaxis; moreover immune 
modulation associated with worse outcome (Niemann, 2010; Hannaman & Hevesi, 2011). 
Diuretics can be used to maintain euvolemic conditions and reduce transfusion requirements. 
Mannitol, with its potential for free radical scavenging and antioxidant properties, can help 
to remove free water in the abdominal organs, which is due to the congestion of blood flow 
through the fibrosed liver; particularly being useful in hepatorenal syndrome. Mannitol can 
be used before clamping or during the anhepatic phase (Vater et al, 2004) (Table 3).  
Calcium chloride administration during the absence of hepatic functions avoids citrate 
intoxication related with the infusion of citrate rich blood products (Scott et al, 1996).  
The risk of an air embolism during the manipulation of vena cava should be considered in 
case of sudden decrease in expired carbon dioxide associated with hemodynamic instability. 
3.4.2 The anhepatic phase 
The anhepatic phase starts with the occlusion of blood inflow to the liver and ends with 
graft reperfusion. The procedure of clamping the inferior vena cava and portal vein, and  
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dividing the hepatic vasculature (including IVC) results in the loss of venous return leading 
to a high risk of cardiovascular collapse with a marked decrease in cardiac output and 
hypotension. The resulting increase in distal venous pressure may increase bleeding, impair 
renal perfusion and often promotes edema and ischemia of intestines. This may be 
overcome by veno-venous bypass which involves cannulation of portal and femoral veins, 
diverting the blood flow from IVC and portal veins to the axillary vein; improving renal 
perfusion pressure, lessening splanchnic congestion and delaying the development of 
metabolic acidosis (Findlay, 2002; Steadman, 2004). VVB improves hemodynamic stability, 
reduces blood loss, and allows extra time during the anhepatic phase. The first successful 
use of venovenous bypass (VVB) is reported in 1984 (Shaw et al, 1984). Venovenous bypass 
is used only in some centers. Although there are many benefits of venovenous bypass such 
as reducing hemodynamic instability and blood loss during anhepatic phase, maintaining 
intraoperative renal function and cerebral perfusion pressure in patients with acute 
fulminant failure by avoiding rapid swings in blood pressure (Shaw et al, 1984; Chari et al, 
1998; Grande et al, 1996; Veroli et al, 1992), the use of it is not without risk such as; air 
embolism, thromboembolism, brachial plexus injuries and incorrect cannulation which may 
be mortal and may increase the risk of morbidity. The decision of using VVB depends on 
medical team experiences, preferences and judgement. The volume restriction brings the 
usage of vasopressors, as an alternative to veno-venous bypass. Transient inotropic support 
in addition to blood and fluid replacement is often required until effective veno-venous 
bypass is established. Norepinephrine and vasopressin improve circulatory stability and 
renal perfusion without impairing the mesenteric blood flow (Wadei et al, 2006; Alessandra 
et al, 2007). In order to preserve renal functions, prophylactic mannitol administration prior 
to and during venous clamping may be beneficial.  
Transfusion of blood leads to a large citrate load that can no longer be metabolised when the 
liver is removed, resulting in hypocalcemia and secondary myocardial depression. 
Treatment with periodic calcium chloride administration should be guided by ionized 
calcium concentration measurements to avoid hypercalcemia. On the other hand, acid 
metabolites originating from intestine and lower body cannot be cleared in the absence of 
liver, resulting in progressive acidosis. Sodium bicarbonate therapy should be guided by 
arterial blood gas analysis, because excessive administration may result in hypernatremia, 
hyperosmolality and metabolic alkalosis. Although hypoglycemia can occur, hyperglycemia 
is more likely, due to the large amounts of transfused blood products. Glucose containing 
solutions are not used unless hypoglycemia is documented. Due to absence of a liver 
produced plasminogen activator inhibitor, fibrinolysis may begin during this phase. During 
this significantly notable phase platelets and coagulation factors continue to decrease. 
Antifibrinolytic strategies differs among centers. Postreperfusion syndrome may follow 
within a few minutes with severe hypotension, decreased heart rate, and a major decrease in 
systemic vascular resistance together with an increase in pulmonary artery pressure (Table 3).  
After hepatectomy, vascular anastomoses of the supra- and infra-hepatic inferior vena cava 
and the portal vein are performed. 
3.4.3 The neohepatic phase 
In neohepatic phase, when the venous anastomosis to the graft is completed, the liver is 
flushed with blood and the clamp on IVC is released. This reperfusion of the graft is  
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associated with elevations of potassium and hydrogen ion concentrations, increase in 
preload and decrease in systemic vascular resistance with a decrease in blood pressure. 
Aggarwal described ‘postreperfusion syndrome’ (PRS) in 1987, and defined it as at least 30% 
decrease in mean systemic blood pressure for more than 1 min during the first 5 min 
following reperfusion and by initial reperfusion of the hepatic artery (Aggarwal et al, 1987; 
Moreno et al, 2006). Despite the restoration of blood volume, electrolyte and acid base 
balance, hypotension and bradycardia are also common. Avoiding excessive fluid 
administration and hypervolemia is one of the intraoperative aims, maintaining a low CVP 
via IV volume restriction or phlebotomy (Massicotte et al, 2006). Besides volume restriction, 
plebotomy or using both; nitroglycerin may become a pharmacological alternative, in 
patients whose blood pressures are tolerable, to keep the CVP low (Massicotte et al, 2006; 
Hannaman & Hevesi, 2011 ).  
Significant hemodynamic changes such as decreased cardiac output, increased splanchnic 
and lower caval pressures, decreased renal perfusion pressure, and reduced systemic 
arterial pressure may be seen during this period. Mediators may be released by the ischemic 
liver including xanthine oxidase, a generator of cytotoxic oxygen radicals which may 
produce myocardial and cellular damage. Strong vasopressors with an alpha-agonist action 
such as norepinephrine may be required (Ramsay et al, 1992). These changes related to 
reperfusion may be decreased by using the piggy back technique contributing to a side-bite 
of IVC allowing the venous return to continue (Findlay, 2002; Gurusamy et al, 2011). Initial 
arterial reperfusion may be preferable only in patients with poor cardiac reserve (Moreno et 
al, 2006). Hypothermia is a marker for the presence of graft outflow into the central 
circulation. Calcium chloride should be given for treating life-threatening hyperkalemia and 
possibly bicarbonate administration must be considered. Electrocardiographic changes 
require prompt treatment. Even in the absence of treatment, increased potassium levels fall 
spontaneously within minutes due to redistribution. The severe coagulation disorder seen in 
this period is mainly multifactorial in its etiology including reperfusion hypothermia, 
ionized hypocalcemia, dilutional coagulopathy, quantitative and qualitative defects in 
platelets, heparin effect, fibrinolysis and humoral substances released by the grafted liver 
(Pvalizza et al, 2001; Hannaman & Hevesi, 2011). Infrequently, excessive activation of 
coagulation may occur during this phase (Gologorsky et al, 2001). 
Coagulation disorders should be corrected during this phase of the surgery to obtain 
sufficient results. However, using blood products may result in hypervolemic state and a 
paradoxical increase in blood requirement. Fibrinolysis, shown by the thromboelastograph, 
should be reversed with aminocaproic acid and antifibrinolytics or cryoprecipitate may be 
required. Thromboelastograph helps assessing both cellular and humoral components of 
whole blood coagulation and fibrinolysis; and also the effects of antifibrinolytic therapy, 
cryoprecipitate, fresh frozen plasma, platelet and protamin as treatment strategies. 
However, there have been some case reports of thromboembolic complications in patients 
treated with antifibrinolytic agents (Manji et al, 1998; Sopher et al, 1997; O’Connor et al, 
2000; Gologorsky et al; 2007; Ramsay et al, 2004; Ellenberger et al, 2006). A systematic review 
and meta-analysis of the safety of antifibrinolytic drugs has not shown any relationship with 
thrombosis in liver transplantation (Molenaar et al 2007). Certainly, antifibrinolytics should 
not be used prophylactically in patients with a history of thrombotic events. 
Signs of liver function which may be seen in the operating room are decreased calcium 
requirements, improvement in acidosis, increased urine output, rising core temperature and 
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biliary output from the graft. As the graft begins functioning the coagulopathy gradually 
improves. Fibrinolysis and heparin effect ceases within 2 hours, coagulation factors and 
platelets begin to increase toward baseline levels; prothrombin time and activated partial 
thromboplastin time reach their baseline values within a few days (Hannaman&Hevesi, 
2011) (Table 3). 
Preanhepatic phase 
 
• Baseline Tests 
• Intravenous antibiotics 
• Warmers 
• Incision 
• Induction of anesthesia 
• Invasive monitoring (arterial catheter, pulmonary catheter) 
• Lower CVP (5 cm H2O), restriction of iv fluid administration, 
phelobotomy if Hgb>10 g/dl 
• Vasopressin (Norepinephrine) to keep mean blood pressure 
(BP)>60 mmHg 
• Epinephrine or dopamine to preserve cardiac output 
(C.O)>5L/min  
• Maintain Hgb >7 g/dl, platelets>40.000, MA (TEG)>45mm, 
fibrinogen>100 mg/dl 
• Prior to clamping, iv mannitol 0.5 g/kg  
• Just before clamping 
• IV Heparin 3-5000 U  
• Increase CVP to 10 cm H2O  
• In severe hypoalbuminemia 25% 
Anhepatic Phase 
 
• Maintain Hgb >7 g/dl 
• IV fluids to keep CVP around 5 cm H20 
• Vasopressin/Norepinephrine to preserve BP>60 mmHg and 
C.O>5 L/min 
• Correct base deficit 
• Normocalcemia 
Neohepatic Phase 
 
• Reperfusion 
• IV vasopressin 1-5 U bolus to keep BP>60 mmHg 
• Euvolemia (CVP 5-10 cm H2O) 
• Dopamine/epinephrine to preserve C.O>5L/min 
• Norepinephrine/vasopressin to preserve BP>60 mmHg 
• Transesophageal Echocardiography if necessary  
• Maintain Hgb>7 g/dl, platelets>40.000, fibrinogen>100 mg/dl  
• TEG: 
• Protamin 30 mg iv if R is more 
• Maintain MA>45 mm with platelet infusion 
• If Ly30>8% iv EACA 5gr  
• Consider fast tracking 
Table 3. The evidence-based protocol for liver transplantation that is outlined by University 
of Wisconsin (Hannaman & Hevesi, 2011) 
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3.5 Sodium, potassium and glucose management in organ transplantation 
A lot of recent studies have investigated electrolyte and glucose management in organ 
transplantation. In the last decade, anesthesiologists paid attention to intraoperative glucose 
management. Interaction between glycemic control and organ transplantation were recently 
reviewed (Marwin&Morton, 2009). Hyperglycemia increases the expression of adhesion 
molecules and the production of cytokines, increases ischemic damage and the 
inflammatory response to ischemia/reperfusion (Marwin & Morton, 2009). In addition to 
this; the documented risk of hypoglycemia with intensive insulin therapy has led to the 
modification of more conservative glycemic targets, but investigation of glycemic control in 
transplant recipients are limited. Although transplant patients were not specifically 
mentioned, The American Association of Clinical Endocrinologists (AACE) and the 
American Diabetes Association (ADA) reported a consensus statement on glycemic control 
(Moghissi et al, 2009). A perioperative ‘middle ground’ target glucose of between 140 and 
180 mg/dl seems appropropriate (Keegan & Wright, 2010; Lazar et al, 2009). However, 
studies of glucose management in transplant recipients are limited. 
In transplant patients, predictors and potential treatments especially for perioperative 
hyperkalemia has been documented, because hyperkalemia leading to ventricular 
fibrillation is still reported, although in most patients a progressive decrease is seen. A 
retrospective analysis of 1124 liver recipients showed that 10.2% of patients had 
hyperkalemia with high baseline potassium values (Xia et al, 2007). High recipient 
potassium concentrations were found to be an independent predictor of death within the 
first year after liver transplantation (Dawwas et al, 2009). Bank blood transfusion imposes a 
severe potassium increase, and hyperkalemia may complicate the status of the transplant 
patient, especially in the presence of renal impairment and acidemia (Nakasuji& Bookallil, 
2000). Serum potassium concentrations must be checked periodically and prereperfusion 
hyperkalemia must be corrected aggressively. Treatments are administration of insulin–
glucose and/or salbutamol, furosemide, washing of bank blood using cell-salvage 
equipment, and hemodiafiltration. The effectiveness of different volumes of 5% albumin 
solution for the washout of preservation fluid in liver transplant grafts prior to reperfusion 
was measured; proposing the minimal washout fluid volume as 500 ml to reduce the risk of 
postreperfusion syndrome and hyperkalemia (Homvises et al, 2008). During neohepatic 
period baseline hypokalemia, low body weight (pediatric patients), administration of fresh-
frozen plasma units and absence of ascites at surgery were independent predictors for 
hypokalemia (Xia et al, 2006). Potassium should be administered carefully, since it leads to 
hyperkalemia easily and is more likely to be dangerous than no treatment. 
Besides, hyponatremia occurs in approximately 20% of patients with decompensated 
cirrhosis and has been shown to be a predictor of death for patients with end-stage liver 
disease listed for liver transplantation (Kim et al, 2008). The brain adapts to hyponatremia 
by losing intracellular solutes limiting brain edema (Gines P & Guevara, 2008). Treating 
hyponatremia may prevent hepatic encephalopathy. While correcting hyponatremia rapidly 
in the presence of lack of adaptation by the brain may lead to osmotic demyelination 
syndrome. Central pontine myelinolysis (CPM) in liver transplant recipients appear to be 
associated with a rapid rise in serum sodium concentration in previously hyponatremic 
patients (Zhang et al, 2009). This syndrome is often associated with neurological morbidity 
and mortality. A review of 1247 patients undergoing liver transplantation reported 11 
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patients diagnosed with CPM by neurological imaging findings (Lee et al, 2009). Patients 
with hyponatremia can be successfully operated but they are at increased risk of cerebral 
demyelination syndromes. In one report rapid correction of hyponatremia causing a 
perioperative rise of 21-32 Meq/L in the serum sodium were associated with central pontine 
myelinolysis, while an increase of 16 mEq/L was not (Wszolek et al, 1989). The first step in 
management of hyponatremia is determination of the patient’s volume status (Gines P & 
Guevara, 2008).  
3.6 Early-extubation (fast-tracking) 
In general, fast tracking of a patient refers to improvement in quality of care, short length of 
stays in ICU and hospital and reduced costs of total treatment. Prolonged mechanical 
ventilation is no longer desired, for a group of patients devoid of risk factors, following 
orthotopic liver transplantation (OLT). ‘Fast-tracking’ defined as tracheal extubation at the 
conclusion of surgery before leaving the operating room, varies widely among the centers 
for OLT recipients. In liver transplantation the aim is rapid progress from preoperative 
preparation throughout the surgery and early discharge from hospital. Because of the nature 
of this procedure; awaiting recipients for a cadaver liver donor graft, fast-tracking 
contributes to intra- and post-operative surgical and anesthesiological strategies; meaning 
generally a reduction in the postoperative ventilation time (Glanemann, 2007).  
In recent years there is a gradual increase in the number of early extubated recipients 
approaching to approximately 70-80% (Forraz-Neto et al, 1999; Park et al, 2000; Biancofiore 
et al, 2005; Salizzoni et al, 2005). Postoperative positive airway pressure ventilation 
combined with sedation has been known to decrease surgical stress response, improve 
haemodynamic stability and facilitate early recovery; however leading to elevated 
intrathoracic pressures it causes an increase in pulmonary vascular resistance which in turn 
rises right ventricular afterload. The possible associated tricuspit regurgitation there may 
occur venous congestion in the graft (Jullien et al, 1995). On the other hand, spontaneous 
breathing has been shown to reduce intrapleural pressures, improving venous return and 
hepatic blood flow; leading to a better recovery (Kaisers et al, 1995). Fast-tracking combined 
with the restrictive fluid management have been shown to result in rapid recovery (Rossaint 
et al, 1990). 
Fast-tracking of the patients with liver transplantation is usually safe and well tolerated; 
postoperative mechanical ventilation is no longer required for the majority of patients who 
are devoid of risk factors (Glanemann, 2007). However, as the Model for end-stage liver 
disease (MELD)-score based organ allocation system has been introduced, the number of 
patients to be the candidates for fast-tracking is decreased; because it has been shown that 
early extubation also has its own complications including postoperative ventilatory failure 
resulting in impaired oxygen delivery to the new graft and reintubation for early surgical 
complications such as bleeding, bile leak, thrombosis or retransplantation (Mandell et al, 
2007). 
Risk factors for prolonged mechanical ventilation after liver transplantation has been 
described in a statistical analysis. Acccording to this analysis, encephalopathy and a body 
mass index >34 were significantly associated with failure, thus cannot be extubated in the 
operating room. Primary graft dysfunction, renal failure, cardiovascular failure, neurological 
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impairment, use of >12 units of red blood cells and pulmonary edema cannot tolerate 
extubation within 3 hours postoperatively. Acute liver failure, retransplantation, severe 
preservation injury to the graft, mechanical ventilation prior to surgery and use of >15 units 
of red blood cells and fresh frozen plasma require mechanical ventilation at least 24 hours 
postoperatively (Mandell, 2002). 
3.7 Pain management 
Orthotopic liver transplant patients were reported to experience less pain and use less 
morphine in the postoperative period compared to liver resection patients (Moretti et al, 
2002). Chen et al have found morphine consumption significantly lower in patients with 
end-stage liver disease undergoing living-donor liver transplantation; compared with 
healthy living liver donors and patients with liver cirrhosis due to chronic hepatitis B or C 
virus infection and hepatocellular carcinoma undergoing hepatectomy, only on the first 
postoperative day (Chen et al, 2010).  
Epidural anesthesia and analgesia provide a good quality of pain relief after major 
surgery. Cosidering the well known coagulation disorders associated with liver surgery, 
epidural hematoma formation is a major risk. Nowadays, although it seems that epidural 
analgesia for living liver donor is a safe method for analgesia, it may be hazardous for 
recipients because of unpredictable coagulopathies after liver transplantation (Lukanovic 
et al, 2008). 
The type of surgical incision, in particular upper midline compared with subcostal incision 
affects postoperative pain, but the safety and efficacy needs to be further evaluated (Kim et 
al, 2009).  
3.8 Postoperative adverse events 
3.8.1 Early complications (Table 4) 
Hypothermia: In the intensive care units it takes 3-8 hours to warm a patient; during this 
period of hypothermia and warming there is always a risk of arrhtyhmias. Also during this 
period, shivering causes the metabolic rate to increase. 
Prolonged mechanical ventilation: Over 72 hours of mechanical ventilation is required for 
15% of the patients; mainly due to preoperative malnutrition, postoperative hemmorhage 
and primary non-functioning donor graft. 
Bleeding: The requirements for blood transfusion continues also in the postoperative 
period. In reoperations a bleeding site is often found, however in a majority of patients this 
can also be caused by coagulopathy. Prothrombin time may remain high in the 
postoperative period and also trombocytopenia may develop because of the sequestration 
during recirculation. Thromboelastogram is a useful monitor also for the coagulopathy in 
the postoperative period. 
Hypertension: The hyperdynamic circulatory state tends to become normal during the 
posttransplantation period, however in 55-85% of patients hypertension may develop, 
resulting in intracranial hemorrhage. 
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Impaired liver function tests: Within the first 48-72 hours, inadequate perfusion of the graft, 
venous congestion and edema may lead to functional impairment. However, in the 
following period coagulopathy improves, whereas aminotransferase, alkalene phosphatase 
and bilirubin levels start to decrease. 
Malnutrition: The patients with end-stage liver disease are often malnourished and have 
depleted protein stores. Following transplantation protein catabolism occurs, leading to a 
negative nitrogen balance within a month. This protein catabolism results in an increase in 
urinary 3-methylhistidine levels, revealing this catabolism originates from muscle. 
The primary non-functioning of donor graft: The increase in the levels of liver enzymes 
within 1 week after transplantation refers to acute cellular rejection, which requires biopsy 
for the definitive diagnosis. Retransplantation is necessary before the other organs are 
affected. 
Sepsis: Most of the patients are transfered back to the ICU because of sepsis, following their 
discharge from ICU. Selective intestine decontamination may limit bacterial infections, 
however non-bacterial organisms contribute to a major problem. 
Others: Bile leak, thrombosis of hepatic artery and portal vein may be major complications 
during this period. Moreover, hyperglycemia, renal insufficiency and neurologic 
impairments may also occur, as side-seffects of immunsuppressive therapy. 
3.8.2 Late complications (Table 4) 
Obesity (30-40%), hyperlipidemia (30%), diabetes (13-30%), osteoporosis and malignancy 
may occur due to the long-term immunsuppressive therapy (Lopez et al, 2006). 
Early Complications 
• Hypothermia 
• Prolonged mechanical ventilation 
• Bleeding 
• Hypertension 
• Impaired Liver Function Tests  
• Malnutrition  
• The primary non-functioning of donor graft  
• Sepsis  
• Others  
Late Complications 
• Obesity  
• Hyperlipidemia  
• Diabetes  
• Osteoporosis  
• Malignancy 
Table 4. Postoperative Adverse Events after liver transplantation 
4. Anesthesia for non-transplant surgery in liver-transplanted patients 
Liver transplant recipients may return to the operating room for reexploration, which is 
frequently for biliary reconstruction. In these cases, liver usually functions normally, leading 
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to anesthetic considerations including regional techniques such as epidural catheters similar 
to any abdominal procedure (Baker et al, 2005). The liver grafts that are functioning 
appropriately can metabolize the drugs effectively, however this functioning should be 
assessed. Coagulation abnormalities should be treated with vitamin K or FFP, ascites with 
diuretics or paracenthesis and encephalopathy should be avoided with lactulose 
administration and careful use of sedatives; these may improve outcome in these patients. 
Renal functions should also be assessed, moreover hypertension may be a common problem 
in these patients. Stress dose of corticosteroids may be required for patients who receive 
chronic supplementation. Because of the powerful immunsuppressive therapy, steril 
conditions should be optimized for the placements of venous and epidural catheters. Drugs 
that may decrease hepatic blood flow should be avoided (Steadman, 2004). 
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